中山大学肿瘤防治中心2017年
博士后招聘启事
中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所）成立于1964年3月，是新中国成立最早的四所肿瘤医院之一。中心是全国规模最大、学术力量最雄厚的集医疗、教学、科研、预防于一体的肿瘤学基地之一，学科地位、综合实力居全国领先水平。
现实际开放病床数1489张，设有32个业务科室，8个职能处室，2个研究科室。2016年门诊量达83万余人次，出院人数近9.4万余人次，医疗业务量居全国肿瘤专科医院前列。医疗技术水平领先，拥有软硬件条件亚洲一流的放射治疗中心、开展多个专科手术机器人微创手术。
中心是国家重点学科（肿瘤学）、国家重点实验室（华南肿瘤学国家重点实验室）。科技影响力稳居“中国医院科技影响力排行榜”（肿瘤学）前两位。共有75个项目获得省部级以上科研成果奖励，其中包括国家自然科学二等奖1项、国家科技进步二等奖4项等。主办英文学术期刊 Chinese Journal of Cancer，2014年被SCI收录，2015年影响因子2.814，在国内被收录肿瘤学期刊中位列第一。
中心以优秀的文化引才、聚才，凝聚高水平的医教研队伍，现有员工2645人。中心通过优化管理体制，推进软硬件建设，建成了就医方便、流程合理、宾至如归的花园式人文医院；继承“诚实、友爱、敬业、创新”的文化因子，2016年荣获中国医疗机构最佳雇主排行榜冠军。
中心拥有良好的科研平台、完善的学科结构和雄厚的经费支持，可为博士后提供优厚的福利待遇和广阔的发展空间。2017年面向海内外招聘博士后研究人员79位，欢迎有志于肿瘤防治研究事业的优秀博士毕业生加入！招聘事项如下：
一、招收条件：
1、取得博士学位，品学兼优，身心健康，具备较高的学术水平和较强的科研能力。
2、首次进站人员年龄一般在35岁以下，博士毕业不超过两年。企业、基地博士后、留学回国人员、外籍人员、拟进二站人员、特别优秀的人员年龄可放宽到40岁以下，无博士毕业与博士后进站间隔年限限制。
3、科研博士后原则上不接受在职人员的申请。
4、在本校获得博士学位的毕业生，不得申请进入校内相同一级学科的流动站。
二、福利待遇：
1、年薪20-25万元（税前）
2、缴纳五险一金。
3、解决广州市户口。
4、在站期间业绩优秀，可申请本中心专职科研人员职位；在站期间发表IF 10以上论文，可根据岗位需要，申请调入。
三、出站要求：在站期间发表IF 3.0以上SCI论文1篇以上，获得科研基金1项以上。
四、招聘人数及期限：77名，常年招聘，额满为止。
五、招聘程序
1、申请者选择合作导师，与导师沟通，确定合作意向。导师信息及专业要求见附件，也可在中山大学【博士后之家】或本中心官网【名医名家】查阅。
2、投递简历。申请者可选择以下三种方式投递简历：（1）将简历发到合作导师邮箱；（2）将简历上传到在本中心诚聘英才/博士后岗位；（3）将简历发到由本中心人事处老师邮箱，由人事处老师推荐合作导师。
3、进站面试。由本中心博士后管理小组专家对申请者进行面试（国外申请者可进行视频面试）。申请者须做15-30分钟学术报告，主要内容包括申请者的基本情况，以往研究工作经历，今后的研究方向，以及与合作导师研究方向一致性等。
4、提交材料。申请者根据中山大学博士后之家/博士后进站材料一览表要求，进入中国博士后网进行网上申报；准备好相关材料，提交本中心人事处老师审核。
5、上报审批。由本中心人事处对应聘者提交的材料进行初审，通过初审的材料再提交中山大学博士后管理办公室审核，最后报广东省人事厅审批。此过程约需一个月左右。
六、联系方式
联系人：杨老师 文老师
联系地址：广州市越秀区东风东路651号 中山大学肿瘤防治中心人事处
电话：020-87343130、87343129
邮箱：yangping@
QQ群（博雅斋）：157357002
2017 Sun Yat-sen University Cancer Center
Postdoctoral Positions
Sun Yat-sen University Cancer Center (SYSUCC) was established in 1964 and is one of the four earliest tumor hospitals in China. SYSUCC is leading the way on a national frontier. It is the largest integrated cancer center in the whole of southern China for cancer care, education, research and prevention.
SYSUCC is a modern medical service provider equipped with 1489 ward beds, 32 clinical departments, 8 administrative offices and 2 research departments. In 2016, the center performed 830,000 out-patients consultations and 94,000 patients were hospitalized, providing the largest volume of cancer medical service in China. Equipped with state of the art medical technology, SYSUCC has a premier radiation therapy center and recently introduced the da Vinci robot for minimally invasive surgeries.
Sun Yat-sen University Cancer Center has been awarded many prestigious titles: the National Key Disciplines (Oncology), the State Key Laboratory (SKL) of Oncology in South China, etc. SYSUCC has always closely combined its clinical and research attributes, ranking top two in the Chinese Hospital of Scientific Impact Ranking.
Altogether, seventy-five projects have been awarded with scientific achievement awards of provincial level or above, including one project with the second prize of “National Natural Science Award”, four projects with the second prize of “National Science and Technology Progress Award”. SYSUCC houses the editorial office of the Chinese Journal of Cancer (CJC). In 2014, CJC became Science Citation Indexed (SCI), and its impact factor of 2015 reached 2.814, ranking first among the national journals of Oncology.
With over 2,500 staff members, Sun Yat-sen University Cancer Center has recruited a talented team for patient care, education and scientific research. Through infrastructure optimization, software and management system upgrades, SYSUCC has created an efficient working environment for its employees, as well as a patient-oriented atmosphere. In 2016, SYSUCC was ranked first in the Chinese Hospitals Best Employer Ranking.
With the establishment of high level research platforms, a mature discipline structure as well as strong funding support, SYSUCC is now offeringgenerous post-doctoral researcher benefits and promising career opportunities. In 2017, 79post-doctoral positions will be made availableat SYSUCC. Enthusiastic applicants with a recent PhDand related research background arestrongly encouraged to apply.Join us and investigate inthe fields of cancer treatment and prevention.
Eligibility Requirements:
1. Good general health, with a doctor’s degree, high academic achievements and strong research ability
2. For recent PhD graduates: you must be under the age of 35 and have completed your PhD degree within the last 2 years.
For Post-docs from industry, postdoctoral bases, abroad, foreign or outstanding applicants: must be under the age of 40.
3. To commit to a full-time employment position.
4. For SYSU PhD graduates only: you mustnot apply to the Postdoctoral Training Stationfor the same discipline.
Welfare and Benefits
1. Annual salary: 200,000 – 250,000 RMB (before tax)
2. Pay the basic social insurance and housing fund (for Chinese applicants)
3. Guangzhou hukou (for Chinese applicants)
4. Post-docs with excellent academic performance can apply for a researcher’s position in SYSUCC afterwards.
Requirement for Postdoctoral Training Completion
You must publish at least one SCI paper with an impact factor above 3.0and receive at least one research funding grant in order to gain the post-doc training certificate. Information and help about funding opportunities at that stage will be disclosed at a later date.
Total number of enrollment:77
Application procedure
1. Please communicate first with potential supervisors. Attached is the contact information and research specialty for each of the supervisors. You can also check SYSUCC official website or the following website: rs***.cn[点击查看]
2. Please submit your CV by: (1) sending it to your supervisor via email. (2) submit it online to our Chinese website(3)send it to our Human Resources Department, and we will then help to recommend you to suitable supervisors
3. Interview: experts from the Post-doc Administration Group are in charge of interviewing all applicants(international applicants can be interviewed via teleconferencing). A 15-30 minute academic presentation is required, including a general self-introduction, introduction of your former research experience as well as your future work plan.
4. Document submission: applicants should prepare all the materials as required (rs***.cn[点击查看]), and submit themto the following website: ww***.cn[点击查看] Please prepare the related documents for review by our HR team.
5. Approval: After approval by our HR, documents will be submitted to the Office of Postdoctor Management at Sun Yat-sen University, and then to the Personnel Department of Guangdong Province for final approval. The whole procedure takes approximately 30 days.
Contact
Contact person: Mrs. Yang, Mrs. Wen
Address: Personnel Department, Sun Yat-sen University Cancer Center, No. 651 Dongfeng East Road, Yuexiu District, Guangzhou, China
Tel: 86 20 87343130, 86 20 87343129
Email: yangping@
QQ: 157357002
附：招收信息
|
序号 |
合作导师姓名Supervisor |
二级学科Second-level discipline |
研究方向Field of research |
招收人数 | |||
|
中文 |
英文 |
中文 |
英文 |
中文 |
英文 | ||
|
1 |
夏小俊 |
Xiaojun Xia |
分子医学 |
Molecular Medicine |
天然免疫和肿瘤免疫治疗 |
Innate immunity&Cancer immunotherapy |
2 |
|
2 |
刘学奎 |
XuekuiLiu |
头颈肿瘤学/耳鼻喉科学 |
Head and neck /oncologyotolaryngology |
喉癌的基础和临床研究 |
Basic and clinical research of laryngeal cancer |
1 |
|
3 |
曾益新 |
Yi-Xin Zeng |
肿瘤学 |
Oncology |
恶性肿瘤的发病机理及肿瘤的生物治疗 |
Mechanisms of cancer pathogenesis andbiotherapy |
2 |
|
4 |
黄必军 |
Bi-Jun Huang |
肿瘤学 |
oncology |
肿瘤干细胞 |
Cancer stem cells |
1 |
|
5 |
林东昕 |
Dongxin Lin |
肿瘤学 |
Oncology |
肿瘤分子生物学 |
Molecular Oncology |
2 |
|
6 |
郑健 |
Jian Zheng |
肿瘤学 |
Oncology |
肿瘤分子生物学 |
Molecular Oncology |
1 |
|
7 |
文石军 |
Shijun Wen |
肿瘤学，药物化学 |
Oncology, Medicinal Chemistry |
抗肿瘤药物及有机合成方法学研究 |
Anticancer drug discovery and the development of organic synthetic methodology |
2 |
|
8 |
陈帅 |
Shuai Chen |
肿瘤学 |
Oncology |
免疫调节与癌变 |
Immune regulation and carcinogenesis |
2 |
|
9 |
唐海林 |
HailinTang |
肿瘤学 |
Oncology |
肿瘤学 或 分子医学 |
Oncology or Molecular Medicine |
1 |
|
10 |
马骏 |
Jun Ma |
肿瘤放射治疗学 |
Radiotherapy of Oncology |
鼻咽癌分子预后与多学科精准治疗 |
Molecular prognosis and multidisciplinary precision therapy of nasopharyngeal carcinoma |
4 |
|
11 |
石明 |
Shi Ming |
肿瘤学 |
Oncology |
肝癌 |
hepatocellular carcinoma |
1 |
|
12 |
邵建永 |
JianyongShao |
肿瘤学 |
Oncology |
肿瘤高通量测序和数据挖掘 |
Tumor high-throughput sequencing and data mining |
1 |
|
13 |
李晓星 |
Xiaoxing Li |
肿瘤学 |
Oncology |
肿瘤分子生物学 |
Molecular Oncology |
1 |
|
14 |
郑晓峰 |
Xiao-Feng Steven Zheng |
肿瘤学 |
Oncology |
肿瘤分子生物学 |
Molecular Oncology |
3 |
|
15 |
吕跃 |
Yue Lu |
肿瘤学 |
Oncology |
血液肿瘤学 |
Hematologic Oncology |
1 |
|
16 |
陈忠平 |
Zhong-ping Chen |
肿瘤学 |
Oncology |
血管拟态 |
Vascular mimicry |
2 |
|
17 |
李疆 |
Jiang Li |
肿瘤学 |
Oncology |
肿瘤免疫 |
Cancer Immunology |
1 |
|
18 |
夏云飞 |
Yunfei Xia |
肿瘤学 |
Oncology |
放射肿瘤学 |
Radiation Oncology |
1 |
|
19 |
符立梧 |
Liwu Fu |
肿瘤学 |
Oncology |
肿瘤药理学 |
Cancer Pharmacology |
3 |
|
20 |
关新元 |
Xin-Yuan Guan |
分子生物学 |
Molecular Biology |
肿瘤微环境和肿瘤发生 |
Microenvironment and tumorigenesis |
1 |
|
21 |
李 焱 |
Yan Li |
肿瘤学 |
Oncology |
肿瘤发生分子机制 |
Molecular tumorigenesis |
1 |
|
22 |
刘强 |
Quentin Qiang Liu |
肿瘤学 |
Oncology |
肿瘤分子靶向治疗 |
Molecular Target Therapy |
2 |
|
23 |
徐瑞华 |
Rui-huaXu |
肿瘤学 |
Oncology |
胃肠肿瘤精准治疗 |
Precise treatment in gastrointestinal cancer |
5 |
|
24 |
曾木圣 |
MushengZeng |
肿瘤学／病毒学 |
tumor biology／virology |
EBV感染及EBV疫苗/肿瘤标志及分子显像/肿瘤免疫机制及免疫治疗 |
EBV infection and EBV vaccine/tumor marker and molecular imaging/ Tumor immune mechanism and immunotherapy |
2 |
|
25 |
高嵩 |
Song Gao |
分子医学 |
Molecular Medicine |
抗肿瘤药物靶点的结构解析 |
Structural study of anti-tumor drug targets |
1 |
|
26 |
孙颖 |
Ying Sun |
肿瘤放射治疗学 |
Radiation oncology |
鼻咽癌分子预后与多学科精准治疗 |
Molecular prognosis and multidisciplinary precision therapy of nasopharyngeal carcinoma |
2 |
|
27 |
谭静 |
Jing Tan |
肿瘤学 |
Oncology |
肿瘤的精准诊疗 |
Precision Medicine of Cancer |
4 |
|
28 |
刘然义 |
Ran-yi Liu |
肿瘤学 或 分子医学 |
Oncology or Molecular Medicine |
恶性肿瘤靶向治疗 |
Malignant tumor targeting therapy |
2 |
|
29 |
黄蓬 |
Peng Huang |
肿瘤学，分子医学，药学 |
Oncology, molecular medicine, pharmacology |
肿瘤代谢异常的调控机制与药物干预的研究，抗肿瘤药物的研发 |
Regulatory mechanisms of metabolic alterations in cancer and pharmacological intervention. Development of novel anticancer agents. |
3 |
|
30 |
李安华 |
Anhua Li |
超声医学 |
Medical Ultrasound |
介入超声 |
Interventional Ultrasound |
1 |
|
31 |
钱朝南 |
Chao-Nan Qian |
肿瘤学 |
Oncology |
肿瘤转移分子机制，或肿瘤血管劫留的分子机制 |
The molecular mechanisms underlying metastasis or vessel co-option in solid tumor |
1 |
|
32 |
黄文林 |
Wenlin Huang |
肿瘤学 或 分子医学 |
Oncology or Molecular Medicine |
肿瘤分子生物学 |
Cancer Molecular Biology |
2 |
|
33 |
郑利民 |
LiminZheng |
肿瘤学 |
Oncology |
肿瘤免疫 |
Tumor immunology |
1 |
|
34 |
朱孝峰 |
Xiao-Feng Zhu |
肿瘤学 |
Oncology |
肿瘤信号转导与靶向药物 |
Signal transduction and targeted anticancer drug |
1 |
|
35 |
张力 |
Zhang Li |
肿瘤学 |
Medical Oncology |
1、肺癌及鼻咽癌新药的临床前研究；2、肺癌及鼻咽癌分子分型及靶向药物治疗研究 |
1、Studies of preclinical drug treating lung cancer and nasopharyngeal carcinoma； 2、Molecular classification and targeted drug therapy of lung cancer and nasopharyngeal cancer |
2 |
|
36 |
贝锦新 |
Bei Jin-Xin |
肿瘤学 |
Oncology |
肿瘤遗传学和基因组学；生物信息学 |
Cancer Genetics and Genomics；Bioinformatics |
2 |
|
37 |
谢丹 |
Dan Xie |
肿瘤学 |
Oncology |
消化系统肿瘤转移机制 |
The mechanisms of metastasis in GI tumors |
2 |
|
38 |
贾卫华 |
Wei-HuaJia |
流行病学/肿瘤学 |
Oncology/Epidemiology |
肿瘤遗传与基因组学，肿瘤流行病学 |
Cancer genetics and genomes; Cancer epidemiology |
2 |
|
39 |
周芳坚 |
Fangjian Zhou |
肿瘤学 |
Oncology |
膀胱癌发病机制的研究 |
The mechanism of bladder urothelial carcinoma |
1 |
|
40 |
张星 |
Xing Zhang |
肿瘤学 |
Oncology |
分子靶向治疗和免疫治疗 |
New molecular targeted therapy and immunotherapy |
1 |
|
41 |
张福君 |
Fujun Zhang |
肿瘤学 |
Oncology |
分子影像学；肿瘤微创治疗 |
Molecular imaging；Minimally invasive treatment of tumor |
2 |
|
42 |
邓务国 |
Wuguo Deng |
肿瘤学 |
Oncology |
肿瘤基因表达调控 |
Tumor gene expression regulation |
2 |
|
43 |
夏建川 |
JianchuanXia |
免疫治疗 |
immunotherapy |
肿瘤免疫治疗、肿瘤病因学 |
Tumor immunotherapy、Tumor etiology |
1 |
|
44 |
麦海强 |
Hai-Qiang Mai |
临床医学 |
Clinical medicine |
鼻咽癌 |
Nasopharyngeal carcinoma |
1 |
|
45 |
买世娟 |
Shi-Juan Mai |
肿瘤学 |
Oncology |
肿瘤转移标志物 |
Tumor metastasis biomarker |
1 |
|
46 |
宋立兵 |
Li-Bing Song |
肿瘤学、分子医学 |
Oncology; Molecular medicine |
肿瘤分子机制及其标记物 |
Molecular Mechanism & Biomarker of Tumor |
1 |
|
47 |
杨大俊 |
Da-Jun Yang |
肿瘤学 |
Cancer Biology and target therapy |
靶向药物个体化治疗的转化研究 |
Anti-cancer drug research and translational research |
2 |
|
48 |
曹素梅 |
Su-Mei Cao |
肿瘤流行病学 |
Cancer Epidemiology |
肿瘤流行病学；肿瘤筛查 |
Cancer Epidemiology |
2 |
